IOL Chemicals & Pharmaceuticals
add_icon

IOL Chemicals & Pharmaceuticals

172.37
+3.29
(1.95%)
Market Cap
5,059.53 Cr
PE Ratio
29.53
Volume
48,08,790.00
Day High - Low
176.50 - 167.63
52W High-Low
179.60 - 67.19
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
5,059.53 Cr
EPS
4.69
PE Ratio
29.53
PB Ratio
2.76
Book Value
61.27
EBITDA
290.30
Dividend Yield
0.59 %
Industry
Healthcare
Return on Equity
7.65
Debt to Equity
0.07
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
IOL Chemicals & Pharmaceuticals reported a 90% YoY rise in Q1 FY27 net profit to ₹64.5 crore, driven by higher capacity utilization and export growth. Revenue rose 37% to ₹756 crore.
positive
IOL Chemicals & Pharmaceuticals reported a 90.5% YoY rise in Q1FY27 PBT to ₹86.8 crore, driven by 37.1% revenue growth and margin expansion.
positive
IOL Chemicals Q1 Results: Net Profit Nearly Doubles YoYAug 10, 2026
IOL Chemicals Q1 net profit rose to 650M rupees from 340M YoY; revenue surged to 7.6B rupees from 5.5B, while EBITDA margin expanded to 16% from 14.1%.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,922.00
#1 4,61,152.18
37.82
#1 61,673.90
12.69
#1 11,565
26.53
49.61
8,744.50
2,32,139.00
77.15
11,067.00
13.95
2,568
65.50
73.16
4,932.00
1,87,597.43
85.76
13,886.20
20.34
2,138
3.28
51.36
1,422.00
1,14,875.60
34.55
29,044.60
2.24
3,870
-39.18
42.83
1,124.50
1,13,151.01
23.91
27,657.90
17.64
5,026
-34.90
49.80
1,866.20
1,00,748.04
89.01
6,867.80
22.01
890
#1 123.93
68.10
1,193.50
99,617.75
31.32
35,058.60
3.90
4,158
-69.10
49.57
2,175.50
99,470.94
#1 18.04
29,038.90
#1 26.75
5,356
16.00
26.80
2,365.00
97,673.55
47.44
14,636.40
14.85
1,938
29.13
37.36
1,617.80
93,084.64
24.96
34,145.20
5.56
3,503
25.21
53.16
Growth Rate
Revenue Growth
11.36 %
Net Income Growth
36.10 %
Cash Flow Change
19.99 %
ROE
27.71 %
ROCE
21.69 %
EBITDA Margin (Avg.)
16.09 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
579
570
547
530
596
570
552
529
511
510
532
527
532
559
574
586
621
764
Expenses
527
509
510
481
492
491
481
476
454
451
484
476
465
490
511
534
527
653
EBITDA
52
61
37
49
104
80
71
53
57
59
48
51
67
70
64
51
94
112
Operating Profit %
8 %
10 %
6 %
8 %
16 %
13 %
12 %
9 %
10 %
10 %
8 %
9 %
12 %
11 %
10 %
8 %
15 %
14 %
Depreciation
11
11
11
12
12
14
16
16
16
17
18
19
19
20
20
20
20
21
Interest
2
3
4
5
5
4
4
4
3
2
4
5
4
4
4
4
3
4
Profit Before Tax
39
47
22
33
87
61
51
32
37
40
26
28
45
46
41
28
71
87
Tax
9
12
6
9
22
15
13
9
10
10
7
7
13
12
11
7
18
22
Net Profit
30
35
16
24
65
46
38
23
28
30
19
21
31
34
30
21
53
64
EPS in ₹
5.07
5.91
2.71
4.05
11.03
7.81
6.45
3.93
4.71
5.11
3.26
3.50
1.07
1.16
1.02
0.70
1.81
2.19

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
1,962
2,022
2,244
2,382
2,587
Fixed Assets
561
752
933
1,171
1,182
Current Assets
1,081
920
1,120
1,151
1,228
Capital Work in Progress
105
90
101
22
96
Investments
2
20
20
21
21
Other Assets
1,294
1,161
1,190
1,169
1,289
Total Equity & Liabilities
1,962
2,022
2,244
2,382
2,587
Current Liabilities
513
456
560
610
690
Non Current Liabilities
57
58
73
85
98
Total Equity
1,392
1,508
1,612
1,688
1,799
Reserve & Surplus
1,334
1,449
1,553
1,629
1,740
Share Capital
59
59
59
59
59

Cash Flow

Cash Flow
2022
2023
2024
2025
2026
Net Cash Flow
-29
-2
6
71
-13
Investing Activities
-121
-120
-191
-154
-198
Operating Activities
93
122
290
179
214
Financing Activities
-2
-4
-93
46
-29

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
52.62 %
52.62 %
52.62 %
52.62 %
52.62 %
57.48 %
62.28 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.34 %
2.18 %
1.41 %
1.39 %
1.63 %
1.49 %
1.47 %
2.59 %
2.25 %
2.08 %
1.72 %
4.87 %
DIIs
0.04 %
0.04 %
0.36 %
0.50 %
0.02 %
0.02 %
0.06 %
0.17 %
0.02 %
0.26 %
0.36 %
0.37 %
0.30 %
0.10 %
0.08 %
0.08 %
0.07 %
0.02 %
0.04 %
0.03 %
0.02 %
0.43 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.30 %
28.03 %
29.86 %
30.15 %
30.29 %
31.15 %
31.15 %
30.92 %
30.49 %
29.28 %
30.28 %
30.63 %
30.98 %
31.48 %
31.31 %
31.23 %
31.43 %
30.22 %
29.97 %
30.51 %
31.03 %
26.95 %
Others
28.97 %
28.24 %
26.08 %
25.66 %
25.99 %
25.14 %
25.10 %
25.23 %
21.30 %
22.26 %
18.84 %
18.62 %
19.12 %
18.84 %
18.79 %
14.58 %
14.40 %
14.54 %
15.12 %
14.76 %
9.74 %
5.47 %
No of Share Holders
1,09,092
1,27,893
1,42,022
1,45,041
1,46,437
1,48,907
1,45,692
1,43,327
1,40,177
1,26,004
1,35,397
1,34,235
1,30,003
1,28,689
1,25,979
1,26,701
1,30,002
1,25,040
1,36,129
1,33,531
1,31,550
1,19,311

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 3 6 4 4 5 0.8 1
Dividend Yield (%) 0.00 0.00 0.00 2.72 8.48 7.07 5.53 8.18 1.1 0.59

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Sept 2026 110.21 169.08
12 Sept 2021 DIVIDEND Dividend
2.00 /share
08 Sept 2021 142.80 110.43
16 Feb 2022 DIVIDEND Dividend
4.00 /share
15 Feb 2022 91.71 77.42
17 Feb 2023 DIVIDEND Dividend
4.00 /share
17 Feb 2023 62.59 63.30
16 Feb 2024 DIVIDEND Dividend
5.00 /share
16 Feb 2024 87.56 82.25
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 74.72 93.30
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 79.07 74.06
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 72.62 73.57
18 Feb 2025 DIVIDEND Dividend
4.00 /share
18 Feb 2025 73.57 68.18
27 Dec 2024 SPLIT Split
2:10
11 Mar 2025 82.27 82.27
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 65.00 77.10
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 94.23 95.10
22 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Aug 2025 77.10 98.25
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 94.32 89.30
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 71.98 80.88
17 Feb 2026 DIVIDEND Dividend
1.00 /share
17 Feb 2026 80.88 74.81
20 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2026 105.71 110.21
10 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Aug 2026 146.33 167.80

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 13, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2026
Communication To The Shareholders Regarding AGM Notice And Annual Report For The Financial Year 2025-26Aug 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 10, 2026
Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026Aug 10, 2026
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026Aug 10, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2026
Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2026
Submission Of Notice Of The 39Th Annual General MeetingAug 07, 2026
Reg. 34 (1) Annual Report.Aug 07, 2026
Board Meeting Intimation for Notice Of Board MeetingAug 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2026
Approval From NMPA China For Clopidogrel Bisulfate APIJul 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJul 01, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 29, 2026
Closure of Trading WindowJun 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2026
Communication To Shareholders Relating To Unclaimed DividendJun 11, 2026
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 10, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 20, 2026
Comments Of Board Of DirectorsMay 20, 2026
Fixed 39Th Annual General Meeting Of The Company And Book Closure Of Register Of MembersMay 20, 2026
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026May 20, 2026
Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026May 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 18, 2026
Board Meeting Intimation for Notice Of The Board MeetingMay 13, 2026
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Disclosure Under Regulation 30 - Participation In Saksham Niveshak CampaignApr 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 01, 2026
Closure of Trading WindowMar 26, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 20, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 20, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 19, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 19, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.01%
-6
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.10%
0
0.00%
-0.01%
Union Active Momentum Fund Direct-Growth
1.45%
0
0.00%
1.45%

Technical Indicators

RSI(14)
Neutral
60.76
ATR(14)
Less Volatile
8.79
STOCH(9,6)
Neutral
38.06
STOCH RSI(14)
Neutral
61.53
MACD(12,26)
Bullish
0.27
ADX(14)
Weak Trend
21.53
UO(9)
Bearish
48.99
ROC(12)
Uptrend And Accelerating
3.62
WillR(14)
Neutral
-39.98